Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) is scheduled to release its earnings data after the market closes on Thursday, February 22nd. Analysts expect Collegium Pharmaceutical to post earnings of $1.27 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link. Collegium […]
Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) had its price objective increased by research analysts at Needham & Company LLC from $36.00 to $40.00 in a report issued on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the specialty pharmaceutical company’s stock. Needham & Company LLC’s target price points to a potential […]
By Ben Glickman Shares of Collegium Pharmaceutical rose Wednesday after the specialty pharmaceutical company guided for higher revenue and adjusted earnings.
This stock was an excellent pick, climbing about 38% since we added it to the Master Buy List just over eight months ago. This more than doubles the rise in the S&P [.]